Johnson & Johnson posts 5% uptick in Q2 orthopedic sales

Johnson & Johnson posted increases in total revenue and orthopedic sales during the second quarter of 2023, according to a July 20 news release from the company.

Advertisement

Five notes:

1. Johnson & Johnson reported $25.5 billion in second-quarter sales, a 6.3 percent increase year over year.

2. Orthopedic sales of $2.3 billion in the second quarter saw a 5 percent increase compared to the same time in 2022. 

3. Hip sales were $397 million, up slightly from $388 million in the second quarter of 2022. Knee sales grew 3.9 percent year over year at $363 million. Trauma sales rose 6.1 percent year over year with $739 million in sales.

4. The spine and sports medicine segment rose 5.8 percent year over year at $766 million.

5. For the first half of 2023, orthopedic sales grew 3.8 percent year over year with $4.5 billion in revenue.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.